Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

← catalyst calendar

NCT04396574 · results posted

Sponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.

Phase
Phase 3
Status
Terminated
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
558actual
Sites
134
Countries
Belgium, Canada, France +12

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Why the sponsor stopped it

Study terminated due to strategic business decision

As filed on the registry record, in the sponsor's own words.

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2020-06-30actualWhen the study began enrolling
Primary completion2025-12-04actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-12-04actualThe whole study's end, after follow-up
First posted2020-05-20actualWhen this record first appeared on the registry
Results posted2026-06-25actualWhen the sponsor posted results to the registry
Record updated2026-06-25actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Migraine

Intervention

  • Drug: Lasmiditan — also filed as LY573144

Primary outcomes

what the primary-completion date above is the date OF
Number of Participants With at Least One Treatment Emergent Adverse Events (TEAEs)
measured Baseline up to 12-month treatment period (Up to 12 Months)
Number of Participants With Discontinuations Due to Adverse Events (AEs)
measured Baseline up to 12-month treatment period (Up to 12 Months)

Posted documents

hosted by the registry — we link, never re-serve
Study Protocolposted 2023-07-20 · 1.5 MB · Prot_000.pdf
Statistical Analysis Planposted 2020-06-10 · 19.5 MB · SAP_001.pdf

Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed